Pfizer's dry-ice box carried a -70C vaccine to a normal hospital.

Pfizer and BioNTech's vaccine had to be held near minus 70C to keep its mRNA intact, but almost no pharmacy, clinic or even warehouse had a freezer that cold, so a normal distribution network could not carry it.

The answer was the box, not the network. Pfizer used a suitcase-sized thermal shipper packed with dry ice that kept the vaccine at ultra-cold temperature for up to ten days, and each box tracked its own location and internal temperature as it moved.

Doses travelled on ordinary FedEx and UPS planes and trucks, and clinics removed the product and used it with only standard cold storage, while the thermal shipper was collected, reused and refilled.

Move the cold chain into the box, not the network

Each box carries its own cold chain, so no node needs a minus-70C freezer.

Dry ice sublimation sustains the temperature without power on the move.

Temperature trackers prove the shipment stayed cold, so it can be used or rejected.

A reusable box spreads the cost across many shipments

When the constraint is one extreme condition, package it rather than rebuild every node it must pass through.

The vaccine reached hospitals worldwide, and the shipping solution showed that a constraint once thought to need a huge new infrastructure could be carried inside a returnable box. It also offered a warning about the fragile cold chain for such products.